CD4 and Pneumocystis infectious disease: Use of infliximab in an HIV-positive patient was associated with the occurrence of OI of P. jiroveci infection even with higher CD4+ count (above 240) than the suspicious level of Pneumocystis infection occurrence in HIV patients, which was thought due to TNF-α use with HIV infection.